| EDUCATION | |
| |
| WORK EXPERIENCES & PRACTICES | |
| |
| OTHER EXPERIENCES | |
| 2015-2017 | Instructor nursing student at Sai noi hospital and Bangbuatong hospital |
| 2015 | Member of Pharmacy and Therapeutics Committee at Bangbuatong hospital |
| 2015 | Emergency Medicine, organized by Phramongkutklao hospital |
| 2016 | Update in internal medicine, organized by Siriraj hospital |
| 2016 | Ambulatory medicine, organized by Chulalongkorn-Ramathibodi-Siriraj hospita |
| 2016 | 5th ECG workshop, organized by Chulalongkorn hospital |
| ACADEMIC ACHIEVEMENTS | |
| Co-author in: Development and validation of a cancer-associated venous thromboembolism clinical risk prediction (CAT-CR) model >> waiting for publication | |
| EDUCATION | |
| |
| WORK EXPERIENCES & PRACTICES | |
| |
| OTHER EXPERIENCES | |
| 2015-2017 | Instructor nursing student at Sai noi hospital and Bangbuatong hospital |
| 2015 | Member of Pharmacy and Therapeutics Committee at Bangbuatong hospital |
| 2015 | Emergency Medicine, organized by Phramongkutklao hospital |
| 2016 | Update in internal medicine, organized by Siriraj hospital |
| 2016 | Ambulatory medicine, organized by Chulalongkorn-Ramathibodi-Siriraj hospita |
| 2016 | 5th ECG workshop, organized by Chulalongkorn hospital |
| ACADEMIC ACHIEVEMENTS | |
| Co-author in: Development and validation of a cancer-associated venous thromboembolism clinical risk prediction (CAT-CR) model >> waiting for publication | |
Professor Bosch is a highly reputed leader in Chronic Lymphocytic Leukemia (CLL) and conducts clinical and basic research on CLL and other lymphoproliferative disorders, focusing on the molecular pathogenesis of CLL and new therapeutic approaches. He has published over 100 articles in prestigious journals and is a professor of haematology at the Vall d'Hebron University Hospital of Barcelona.
Read moreProfessor Bosch is a highly reputed leader in Chronic Lymphocytic Leukemia (CLL) and conducts clinical and basic research on CLL and other lymphoproliferative disorders, focusing on the molecular pathogenesis of CLL and new therapeutic approaches. He has published over 100 articles in prestigious journals and is a professor of haematology at the Vall d'Hebron University Hospital of Barcelona.
Dr. Jaime Pérez de Oteyza is a Spanish hematologist and heads the Hematology and Hematology Oncology Department at HM Hospitales Group. He is an expert in diagnostics and treatment of hematology conditions and hematopoietic stem cell transplant, and has taken part in the first bone marrow transplant in Spain. He holds a degree in general medicine from CEU San Pablo University, has trained in lymphomas pathology at Kiel University, and has a specialty in hematology and hemotherapy from the University of Alcalá. He has won numerous awards for his scientific research and has published over 40 papers on his studies. He is a member of the Spanish Hematology and Hemotherapy Society.
Read moreDr. Jaime Pérez de Oteyza is a Spanish hematologist and heads the Hematology and Hematology Oncology Department at HM Hospitales Group. He is an expert in diagnostics and treatment of hematology conditions and hematopoietic stem cell transplant, and has taken part in the first bone marrow transplant in Spain. He holds a degree in general medicine from CEU San Pablo University, has trained in lymphomas pathology at Kiel University, and has a specialty in hematology and hemotherapy from the University of Alcalá. He has won numerous awards for his scientific research and has published over 40 papers on his studies. He is a member of the Spanish Hematology and Hemotherapy Society.
Prof. Dr. Serdar Bedii Omay graduated from Hacettepe Medical School in 1985 and later specialized in Internal Medicine and Hematology. He has published 65 scientific articles, 112 meeting papers, and 34 conference presentations in the field of Hematology and Bone Marrow Transplantation. He has also worked as a Hematology Specialist and Molecular Hematology Doctor at Japan Mie Medical Faculty in 1995.
Read moreProf. Dr. Serdar Bedii Omay graduated from Hacettepe Medical School in 1985 and later specialized in Internal Medicine and Hematology. He has published 65 scientific articles, 112 meeting papers, and 34 conference presentations in the field of Hematology and Bone Marrow Transplantation. He has also worked as a Hematology Specialist and Molecular Hematology Doctor at Japan Mie Medical Faculty in 1995.
Prof. Baytan is a doctor who graduated from Ankara University Medical Faculty in 1992 and became a Specialist in Medicine at Uludağ University Faculty of Medicine, Department of Child Diseases. He is experienced in the diagnosis and treatment of childhood cancers, leukemia, anemia, and other diseases. He has 15 articles published in international refereed journals, 9 full texts presented and published in international scientific meetings, 3 books/book chapters written, and 8 articles published in local refereed journals.
Read moreProf. Baytan is a doctor who graduated from Ankara University Medical Faculty in 1992 and became a Specialist in Medicine at Uludağ University Faculty of Medicine, Department of Child Diseases. He is experienced in the diagnosis and treatment of childhood cancers, leukemia, anemia, and other diseases. He has 15 articles published in international refereed journals, 9 full texts presented and published in international scientific meetings, 3 books/book chapters written, and 8 articles published in local refereed journals.
Dr. Girish V. Badarkhe is an experienced hematology-oncologist at HCG Manavata Cancer Centre, Nashik, with MBBS, MD, and DM degrees. He has 13+ years of expertise in leukemia, multiple myeloma, and bone marrow transplant, and has received awards for his professional and hard work.
Read moreDr. Girish V. Badarkhe is an experienced hematology-oncologist at HCG Manavata Cancer Centre, Nashik, with MBBS, MD, and DM degrees. He has 13+ years of expertise in leukemia, multiple myeloma, and bone marrow transplant, and has received awards for his professional and hard work.
Prof. Songul Serefhanoglu is a Hematologist at ISU Medical Park since 2019, and has been the Director and President of Adult Hematology Department of Sisli Memorial Hospital, Istanbul since 2019. He completed his Medical Education from Firat University, Elazig/Turkey (1994-2000), Internal Medicine from Inonu University, Malatya/Turkey (2001-2005), and Hematology from Hacettepe University, Ankara/Turkey (2006-2009). He has been involved in peripheral hematopoietic stem cell transplantation, with an average of 100-120/year.
Read moreProf. Songul Serefhanoglu is a Hematologist at ISU Medical Park since 2019, and has been the Director and President of Adult Hematology Department of Sisli Memorial Hospital, Istanbul since 2019. He completed his Medical Education from Firat University, Elazig/Turkey (1994-2000), Internal Medicine from Inonu University, Malatya/Turkey (2001-2005), and Hematology from Hacettepe University, Ankara/Turkey (2006-2009). He has been involved in peripheral hematopoietic stem cell transplantation, with an average of 100-120/year.
Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first bone marrow stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on "Stem Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Stem Cell Research Board. He is the founding president of the STEM CELL FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Stem Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.
His medical interests include:
Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic)
Acute Leukemia
Chronic Leukemia Treatments
Hodgkin Lymphoma
Non-Hodgkin Lymphoma Treatments
Multiple Myeloma Treatments, MDS
Aplastic Anemia
ITP
TTP Treatments
Hypercoagulability
Hereditary Thrombophilia Treatments
Therapeutic Apheresis
Photopheresis
Geriatric Hematology Diseases.
Read moreProf. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first bone marrow stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on "Stem Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Stem Cell Research Board. He is the founding president of the STEM CELL FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Stem Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.
His medical interests include:
Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic)
Acute Leukemia
Chronic Leukemia Treatments
Hodgkin Lymphoma
Non-Hodgkin Lymphoma Treatments
Multiple Myeloma Treatments, MDS
Aplastic Anemia
ITP
TTP Treatments
Hypercoagulability
Hereditary Thrombophilia Treatments
Therapeutic Apheresis
Photopheresis
Geriatric Hematology Diseases.